First range of unlicensed medical cannabis products launched; EMMAC’s products already being prescribed to patients in the UK

9 December 2019, London. EMMAC Life Sciences Group, Europe’s leading independent cannabis company, is pleased to announce that it is has launched its first unlicensed medical cannabis products for the UK and European market. Request more information.